honokiol has been researched along with losartan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Foster, H; Foster, R; Philippou, H; Wilson, C | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Eble, JA; Heemskerk, JWM; Nagy, M; Onselaer, MB; Pallini, C; Perrella, G; Pike, JA; Poulter, NS; Quintanilla, LG; Watson, SP | 1 |
3 other study(ies) available for honokiol and losartan
Article | Year |
---|---|
Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis.
Topics: Binding Sites; Biological Products; Humans; Ligands; Losartan; Molecular Dynamics Simulation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Signal Transduction; Small Molecule Libraries; Thrombosis | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Comparison of the GPVI inhibitors losartan and honokiol.
Topics: Biphenyl Compounds; Blood Platelets; Collagen; Humans; Lectins, C-Type; Lignans; Losartan; Membrane Glycoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Platelet-Rich Plasma; Receptors, IgG; Syk Kinase; Thrombosis | 2020 |